Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector Functions

Clicks: 187
ID: 270499
2009
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Antibodies contain a conserved glycosylation site that has emerged as a target for the modulation of antibody effector functions. The crystal structure of a biosynthetic intermediate of human IgG1, bearing immature oligomannose-type glycans and reported to display increased antibody-dependent cellular cytotoxicity, demonstrates that glycan engineering can bias the Fc to an open conformation primed for receptor binding.
Reference Key
jones2009journalcarbohydrate Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Max Crispin,Thomas A. Bowden,Charlotte H. Coles,Karl Harlos,A. Radu Aricescu,David J. Harvey,David I. Stuart,E. Yvonne Jones;Max Crispin;Thomas A. Bowden;Charlotte H. Coles;Karl Harlos;A. Radu Aricescu;David J. Harvey;David I. Stuart;E. Yvonne Jones;
Journal Journal of molecular biology
Year 2009
DOI
10.1016/j.jmb.2009.02.033
URL
https://sciprofiles.com/publication/view/6b9e99d51d0abe5a0c3295905db39130
Keywords
antibody glycosylation antibody engineering oligomannose kifunensine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.